Presentation is loading. Please wait.

Presentation is loading. Please wait.

Survival and Prognosis After Pneumonectomy for Lung Cancer in the Elderly  Yutaka Mizushima, Hirofumi Noto, Shigeki Sugiyama, Yoshinori Kusajima, Ryouhei.

Published byIda Yuwono Modified over 5 years ago

Similar presentations

Presentation on theme: "Survival and Prognosis After Pneumonectomy for Lung Cancer in the Elderly  Yutaka Mizushima, Hirofumi Noto, Shigeki Sugiyama, Yoshinori Kusajima, Ryouhei."— Presentation transcript:

1 Survival and Prognosis After Pneumonectomy for Lung Cancer in the Elderly 
Yutaka Mizushima, Hirofumi Noto, Shigeki Sugiyama, Yoshinori Kusajima, Ryouhei Yamashita, Tatsuhiko Kashii, Masashi Kobayashi  The Annals of Thoracic Surgery  Volume 64, Issue 1, Pages (July 1997) DOI: /S (97)

2 Fig. 1 Survival curves for younger and elderly groups: (A) all stages (I through IV); (B) stages I and II; and (C) stages IIIA and IIIB. The Annals of Thoracic Surgery  , DOI: ( /S (97) )

3 Fig. 2 Survival curves for groups with central location and peripheral location of tumor: (A) younger group and (B) elderly group. The Annals of Thoracic Surgery  , DOI: ( /S (97) )

Download ppt "Survival and Prognosis After Pneumonectomy for Lung Cancer in the Elderly  Yutaka Mizushima, Hirofumi Noto, Shigeki Sugiyama, Yoshinori Kusajima, Ryouhei."

Similar presentations

Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002  Antonio L Visbal, MD, Brent.

Gender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002  Antonio L Visbal, MD, Brent.
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection  Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival  Elizabeth A. David, MD, Robert J. Canter,

Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival  Elizabeth A. David, MD, Robert J. Canter,
Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study  Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.

Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study  Massimiliano Paci, MD, Alberto Cavazza, MD, Valerio.
Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A

Rodrigo A. S. Sardenberg, MD, Clovis Pinto, MD, Cynthia A
Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis?  Noriyoshi.

Malignant minor pleural effusion detected on thoracotomy for patients with non–small cell lung cancer: is tumor resection beneficial for prognosis?  Noriyoshi.
Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences  Jean Deslauriers, MD, Jocelyn Grégoire,

Sleeve lobectomy versus pneumonectomy for lung cancer: a comparative analysis of survival and sites or recurrences  Jean Deslauriers, MD, Jocelyn Grégoire,
Joshua E. Rosen, BASc, Hari B

Joshua E. Rosen, BASc, Hari B
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.

Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers  Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach1  Mark J Krasna, MD, Carolyn E Reed,

Lung cancer staging and treatment in multidisciplinary trials: cancer and leukemia group B cooperative group approach1  Mark J Krasna, MD, Carolyn E Reed,
Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A

Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer  Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,
Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer  José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,
Lung Cancer Staging: A Case for a New T Definition

Lung Cancer Staging: A Case for a New T Definition
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients  Elizabeth A. David, MD, Stina W. Andersen, PhD,

A Model to Predict the Use of Surgical Resection for Advanced-Stage Non-Small Cell Lung Cancer Patients  Elizabeth A. David, MD, Stina W. Andersen, PhD,

Similar presentations

Ads by Google